Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Jesper Uhd

University of Southern Denmark, Europe

Title: Amplification-free detection of miRNA associated with rheumatoid arthritis by simple hybridization assay

Biography

Biography: Jesper Uhd

Abstract

In our on-going project, we aim at rational design of novel oligonucleotide probes that target miRNA and developing a diagnostic method for clinically relevant microRNA (miRNA, Fig. 1). In my talk, I will discuss our recent studies on the development of highly specific LNA/DNA probes and present the results in testing miRNA levels by the new assay in clinical samples. Nucleic acids and their interactions are the basis of life. To build a reliable theoretical model on the structure and function of nucleic acids, and to apply this model to emerging tasks of life sciences, the detection and studies of nucleic acids must be carried out under biologically relevant conditions. Currently nucleic acids are most often detected by enzymatic amplification. Amplification has multiple disadvantages. First, it affects stoichiometry of the initial sample and cannot be carried out in cells. Secondly, not every sequence can be amplified. Thirdly, enzymes often make mistakes which results in biased detection. At last, amplification is time consuming and costly. As an alternative, efficient probe including modifications, i.e. locked nucleic acids (LNA), can be applied in non-enzymatic assays. The experiments proposed in this project open an exciting opportunity to learn about nucleic acid structure and interactions at biologically relevant low abundance levels and directly in biofluids. Detection and absolute quantification of disease related miRNA presented herein could benefit early diagnosis and treatment of the diseases such as cancer and rheumatoid arthritis.